viewSourceBio International PLC

SourceBio International lands coronavirus testing supply agreement with 'high street retail and pharmacy group'

The company will provide its new customer with lab-based testing service

SourceBio International plc -

SourceBio International plc (LON:SBI) said it has landed a supply agreement with an unnamed high street retail and pharmacy group to provide lab-based testing services to support the roll-out of coronavirus (COVID-19) tests across UK stores.

The company has inked an initial 12-month deal with the offering being trialled initially across a limited number of sites before scaling up.

SourceBio currently provides COVID-19  services to the NHS, the Department of Health & Social Care and private healthcare customers.

"We are delighted to be working in partnership with a major UK high street name to support the roll-out of testing service for their customers across the UK using our ISO 15189 accredited laboratories,” said SourceBio chairman Jay LeCoque in a statement.

"Accurate diagnostic testing is needed more than ever given the new surge in COVID-19 infections in the UK and increasing evidence that many more people may have COVID-19 without showing symptoms than has previously been thought.

“We believe the provision of highly accurate, gold standard, fit to fly, and test to release test results made available on high streets, will be highly sought after and provide much-needed peace of mind to those who still need to go about their daily lives and eventually travel abroad.”

The broker Liberum said this announcement and the recent Oxford Nanopore deal “should reassure investors that SourceBio will play a key role in PCR  [polymerase chain reaction] testing in the UK, a market that continues to be much stronger than we had expected”.

The shares rose 3.5%.

---adds broker note and share price---

Quick facts: SourceBio International PLC

Price: 226.3 GBX

Market: AIM
Market Cap: £167.88 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of SourceBio International PLC named herein, including the promotion by the Company of SourceBio International PLC in any Content on the Site, the...


SourceBio International reveal revenues rose to over £50m for 2020 and set...

SourceBio International PLC's (LON:SBI) Jay LeCoque talks to Proactive London's Katie Pilbeam about their 2020 results.  LeCoque explains what drove revenues for the 12 months ended December 31, 2020, up to £50.7mln, from £21.2mln in 2019. Another headline figure was the underlying...

1 week, 2 days ago

2 min read